Potential peptides in atherosclerosis therapy

Area of Science:

• Cardiovascular Science
• Pharmacology
• Immunology

Background:

• Atherosclerosis is a primary cause of ischemic heart disease, myocardial infarction, and stroke.
• Statins do not provide universal benefit for all patients with atherosclerosis.
• Advances in understanding lipoprotein metabolism, macrophage function, and inflammation have opened new research avenues.

Purpose of the Study:

• To review potential therapeutic peptides for atherosclerosis.
• To explore peptide targets including dyslipidemia, macrophage scavenger receptors, cholesterol metabolism, and anti-inflammatory cytokines.

Main Methods:

• Literature review of current research on therapeutic peptides for atherosclerosis.
• Focus on novel molecular targets and their relevance to disease mechanisms.

Main Results:

• Identification of therapeutic peptides targeting key pathways in atherosclerosis.
• Highlighting peptides that modulate lipid metabolism and inflammation.

Conclusions:

• Therapeutic peptides represent a promising novel strategy for atherosclerosis treatment.
• Targeting dyslipidemia, macrophages, and inflammation with peptides may overcome limitations of current therapies.